Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy

Diabetes Care

Volumn 33, Issue 11, 2010, Pages 2409-2415

  Papale, Massimo ^a   Di Paolo, Salvatore ^b   Magistroni, Riccardo ^c   Lamacchia, Olga ^a   Di Palma, Anna Maria ^a   De Mattia, Angela ^a   Rocchett, Maria Teresa ^a   Furci, Luciana ^c   Pasquali, Sonia ^d   De Cosmo, Salvatore ^e   Cignarelli, Mauro ^a   Gesualdo, Loreto ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Hospital Dimiccoli   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEOME; UBIQUITIN;

ARTICLE; ATHEROEMBOLIC DISEASE; CLASSIFICATION AND REGRESSION TREE ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULAR NEPHROPATHY; MICROALBUMINURIA; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NORMOALBUMINURIA; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEINURIA; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

ALBUMINURIA; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOME;

EID: 78049441143     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0345     Document Type: Article

References (21)

1. U.S. Renal Data System. USRDS 2009 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
2. Colantonio DA, Chan DW. The clinical application of proteomics. Clin Chim Acta 2005;357:151-158 (Pubitemid 40884594)
3. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R, Monga G. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002;39:713-720 (Pubitemid 34263344)
4. Thongboonkerd V. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches. Contrib Nephrol 2008;160: 37-52
5. Merchant ML, Klein JB. Proteomics and diabetic nephropathy. Semin Nephrol 2007;27:627-636 (Pubitemid 350180170)
6. Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007;177:361-368 (Pubitemid 47339533)
7. Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics 2008;8:206-216
8. Ben Ameur R, Molina L, Bolvin C, Kifagi C, Jarraya F, Ayadi H, Molina F, Granier C. Proteomic approaches for discovering biomarkers of diabetic nephropathy. Nephrol Dial Transplant 2010;25:2866-2875
9. Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 2009;20:2065-2074
10. Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P, PREDICTIONS Network. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008; 19:1283-1290
11. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007;30: 638-643 (Pubitemid 46354346)
12. Dihazi H, Müller GA, Lindner S, Meyer M, Asif AR, Oellerich M, Strutz F. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem 2007;53: 1636-1645 (Pubitemid 47340060)
13. Olson JL. Diabetes mellitus. In Heptinstall's Pathology of the Kidney. 5th ed. Jennette SC, Olson JL, Schwartz MM, Silva FG, Eds. Philadelphia, Lippincott-Raven, 1998, p. 1247-1286
14. Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2007;856:205-213 (Pubitemid 47307442)
15. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-3277 (Pubitemid 37430080)
16. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant 2001;16:2337-2347 (Pubitemid 33133847)
17. Mazzucco G, Bertani T, Fortunato M, Fop F, Monga G. The prognostic value of renal biopsy in type 2 diabetes mellitus patients affected by diabetic glomerulosclerosis. J Nephrol 2005;18:696-702 (Pubitemid 43085436)
18. Lapolla A, Seraglia R, Molin L, Williams K, Cosma C, Reitano R, Sechi A, Ragazzi E, Traldi P. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic- nephropathic patients: a MALDI study. J Mass Spectrom 2009;44:419-425
19. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007;156:279-284 (Pubitemid 46554524)
20. Hong CY, Chia KS, Ling SL. Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complications 2000;14:259-265
21. Fung E, Diamond D, Simonsesn AH, Weinberger SR. The use of SELDI Protein- Chip array technology in renal disease research. Methods Mol Med 2003; 86:295-312